Barclays
QGENF

Barclays’s QIAGEN NV QGENF Stock Holding History

Barclays’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-195,575
Closed -$5.48M – 7301
2016
Q4 		$5.48M Buy
195,575
+19,216
+11% +$539K 0.01% 1331
2016
Q3 		$4.84M Buy
176,359
+2,734
+2% +$75K 0.01% 1320
2016
Q2 		$3.79M Buy
173,625
+40,088
+30% +$875K ﹤0.01% 1508
2016
Q1 		$2.94M Sell
133,537
-50,916
-28% -$1.12M ﹤0.01% 1605
2015
Q4 		$4.98M Sell
184,453
-235,253
-56% -$6.35M 0.01% 1319
2015
Q3 		$10.5M Sell
419,706
-209,745
-33% -$5.24M 0.01% 908
2015
Q2 		$15.1M Sell
629,451
-259,060
-29% -$6.22M 0.02% 803
2015
Q1 		$22.2M Buy
888,511
+514,170
+137% +$12.9M 0.03% 630
2014
Q4 		$8.61M Buy
374,341
+55,705
+17% +$1.28M 0.01% 1294
2014
Q3 		$7.01M Sell
318,636
-189,500
-37% -$4.17M 0.01% 1472
2014
Q2 		$12.2M Sell
508,136
-254,688
-33% -$6.11M 0.01% 1004
2014
Q1 		$16M Buy
762,824
+14,335
+2% +$301K 0.02% 830
2013
Q4 		$17.2M Buy
+748,489
New +$17.2M 0.02% 851
2013
Q3 		– Sell
-539,531
Closed -$10.7M – 7988
2013
Q2 		$10.7M Buy
+539,531
New +$10.7M 0.01% 1031

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Barclays's QGENF Position: Q1 2017 in Review

Barclays sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 195,575 shares — an estimated $5.48M sold.

Barclays first reported a position in QGENF in Q2 2013 and held it in 14 quarters. The position peaked at $22.2M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Barclays reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Barclays sold 195,575 QIAGEN NV shares in Q1 2017, an estimated $5.48M.
  • Barclays first reported a position in QIAGEN NV in Q2 2013 and held it in 14 quarters.
  • Barclays's QIAGEN NV position peaked at $22.2M in Q1 2015.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.